Inorganic Chemistry
Article
Part of the synthetic routes, IR spectra, H and 13C
1
(
11) Hussain, A.; Gadadhar, S.; Goswami, T. K.; Karande, A. A.;
Chakravarty, A. R. Photo-induced DNA cleavage activity and
remarkable photocytotoxicity of lanthanide (III) complexes of a
polypyridyl ligand. Dalton T. 2012, 41, 885−895.
NMR spectra, crystal data for RC −RC , crystal
diagrams (Figures S17−S31), a release curve (Figure
1
5
S32), and additional data (PDF)
(12) Wang, L.; Li, W. J.; Song, Y. M. Antitumor activity and DNA
binding studies on rare earth metal complexes with all-trans retinoic
acid and L-glutamic acid. RSC Adv. 2014, 4, 42285−42292.
cam.ac.uk, or by contacting The Cambridge Crystallographic
Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax:
(13) Miller-Shakesby, D. M.; Burke, B. P.; Nigam, S.; Stasiuk, G. J.;
Prior, T. J.; Archibald, S. J.; Redshaw, C. Synthesis, structures and
cytotoxicity studies of p-sulfonatocalix [4] arene lanthanide
complexes. CrystEngComm 2016, 18, 4977−4987.
(14) Hussain, A.; Gadadhar, S.; Goswami, T. K.; Karande, A. A.;
Chakravarty, A. R. Photoactivated DNA cleavage and anticancer
activity of pyrenyl-terpyridine lanthanide complexes. Eur. J. Med.
Chem. 2012, 50, 319−331.
+
44 1223 336033.
(
15) Kumar, S.; Garg, S.; Sharma, R. P.; Venugopalan, P.; Tenti, L.;
AUTHOR INFORMATION
■
*
Ferretti, V.; Nivelle, L.; Tarpin, M.; Guillon, E. Four monomeric
copper(II) complexes of non-steroidal anti-inflammatory drug
Ibuprofen and N-donor ligands: syntheses, characterization, crystal
structures and cytotoxicity studies. New J. Chem. 2017, 41, 8253−
ORCID
8262.
(
16) Yang, C.; Wang, W.; Liang, J.; Li, G.; Vellaisamy, K.; Wong, C.;
Notes
Ma, D.; Leung, C. A rhodium (III)-based inhibitor of lysine-specific
histone demethylase 1 as an epigenetic modulator in prostate cancer
cells. J. Med. Chem. 2017, 60, 2597−2603.
The authors declare no competing financial interest.
(
17) Gill, M. R.; Thomas, J. A. Ruthenium (II) polypyridyl
ACKNOWLEDGMENTS
This work was supported by the National Natural Science
Foundation of China (Grants 21473136 and 21103140).
■
complexes and DNAfrom structural probes to cellular imaging
and therapeutics. Chem. Soc. Rev. 2012, 41, 3179−3192.
(18) Ali, A.; Kamra, M.; Bhan, A.; Mandal, S. S.; Bhattacharya, S.
New Fe (III) and Co (II) salen complexes with pendant distamycins:
selective targeting of cancer cells by DNA damage and mitochondrial
pathways. Dalton T. 2016, 45, 9345−9353.
REFERENCES
■
(
1) Krikavova, R.; Vanco, J.; Travnicek, Z.; Buchtik, R.; Dvorak, Z.
Copper(II) quinolinonato-7-carboxamido complexes as potent
antitumor agents with broad spectra and selective effects. RSC Adv.
016, 6, 3899−3909.
2) Gibson, D. Platinum(IV) anticancer prodrugs − hypotheses and
facts. Dalton T. 2016, 45, 12983−12991.
3) Zamora, A.; Perez, S. A.; Rothemund, M.; Rodriguez, V.;
(19) Choi, S.; Yu, J. Understanding interactions between cellular
matrices and metal complexes: methods to improve silver nanodot-
specific staining. Chem. - Eur. J. 2016, 22, 12660−12664.
2
(
(20) Wang, X.; Ramstrom, O.; Yan, M. Glyconanomaterials:
synthesis, characterization, and ligand presentation. Adv. Mater.
010, 22, 1946−1953.
21) Takara, M.; Toyoshima, M.; Seto, H.; Hoshino, Y.; Miura, Y.
2
(
(
Schobert, R.; Janiak, C.; Ruiz, J. Exploring the Influence of the
Aromaticity on the Anticancer and Antivascular Activities of
Organoplatinum(II) Complexes. Chem. - Eur. J. 2017, 23, 5614−
Polymer-modified gold nanoparticles via RAFT polymerization: a
detailed study for a biosensing application. Polym. Chem. 2014, 5,
9
31−939.
22) Sharon, N. Carbohydrates as future anti-adhesion drugs for
infectious diseases. Biochim. Biophys. Acta, Gen. Subj. 2006, 1760,
27−537.
23) Ohtsubo, K.; Marth, J. D. Glycosylation in cellular mechanisms
of health and disease. Cell 2006, 126, 855−867.
24) Marradi, M.; Chiodo, F.; Garcia, I.; Penades, S. Glyconano-
5
(
624.
(
4) Rosenberg, B.; Van Camp, L. The successful regression of large
solid sarcoma 180 tumors by platinum compounds. Cancer Res. 1970,
0, 1799−1802.
5) Esposito, M.; Collecchi, P.; Brera, S.; Mora, E.; Mazzucotelli, A.;
5
(
3
(
Cutolo, M.; Oddone, M. Plasma and tissue levels of some lanthanide
elements in malignant and non-malignant human tissues. Sci. Total
Environ. 1986, 50, 55−63.
(
particles as multifunctional and multimodal carbohydrate systems.
Chem. Soc. Rev. 2013, 42, 4728−4745.
(
6) Hirano, S.; Suzuki, K. T. Exposure, metabolism, and toxicity of
(25) Shao, C.; Li, X.; Pei, Z.; Liu, D.; Wang, L.; Dong, H.; Pei, Y.
rare earths and related compounds. Environ. Health Perspect. 1996,
04, 85−95.
7) Beyer, G. J.; Franke, W. G.; Hennig, K.; Johannsen, B. A.;
1
(
Facile fabrication of glycopolymer-based iron oxide nanoparticles and
their applications in the carbohydrate−lectin interaction and targeted
cell imaging. Polym. Chem. 2016, 7, 1337−1344.
(26) Yang, R.; Meng, F. H.; Ma, S. B.; Huang, F. S.; Liu, H. Y.;
Zhong, Z. Y. Galactose-Decorated Cross-Linked Biodegradable
Poly(ethylene glycol)-b-poly(ε-caprolactone) Block Copolymer Mi-
celles for Enhanced Hepatoma-Targeting Delivery of Paclitaxel.
Biomacromolecules 2011, 12, 3047−3055.
(27) LEE, Y. C.; LEE, R. T. Carbohydrate-protein interactions: basis
of glycobiology. Acc. Chem. Res. 1995, 28, 321−327.
(28) Parry, A. L.; Clemson, N. A.; Ellis, J.; Bernhard, S.; Davis, B. G.;
Cameron, N. R. ‘Multicopy Multivalent’ Glycopolymer-Stabilized
Gold Nanoparticles as Potential Synthetic Cancer Vaccines. J. Am.
Chem. Soc. 2013, 135, 9362−9365.
(29) Yilmaz, G.; Becer, C. R. Glyconanoparticles and Their
Interactions with Lectins. Polym. Chem. 2015, 6, 5503−5514.
(30) Kohara, K.; Yamamoto, S.; Seinberg, L.; Murakami, T.;
Tsujimoto, M.; Ogawa, T.; Kurata, H.; Kageyama, H.; Takano, M.
Khalkin, V. A.; Kretzschmar, M.; Lebedev, N. A.; Munze, R.;
Novgorodov, A. F.; Thieme, K. Comparative kinetic studies of
simultaneously injected 167 Tm-and 67 Ga-citrate in normal and
tumour bearing mice. Int. J. Appl. Radiat. Isot. 1978, 29, 673−681.
(
8) Xu, Z.; Mao, X.; Jia, L.; Xu, J.; Zhu, T.; Cai, H.; Bie, H.; Chen,
R.; Ma, T. Synthesis, characterization and anticancer activities of two
lanthanide (III) complexes with a nicotinohydrazone ligand. J. Mol.
Struct. 2015, 1102, 86−90.
(
9) Zhou, J.; Wang, L. F.; Wang, J. Y.; Tang, N. Synthesis,
characterization, antioxidative and antitumor activities of solid
quercetin rare earth (III) complexes. J. Inorg. Biochem. 2001, 83,
4
(
1−48.
10) Xu, D.; Ma, S.; Du, G.; He, Q.; Sun, D. Synthesis,
characterization, and anticancer properties of rare earth complexes
with Schiff base and o-phenanthroline. J. Rare Earths 2008, 26, 643−
6
47.
G
Inorg. Chem. XXXX, XXX, XXX−XXX